Perspectives on Anti-HER Monoclonal Antibodies

Publisher： Karger

E-ISSN： 1423-0232|63|1|17-24

ISSN： 0030-2414

Source： Oncology, Vol.63, Iss.1, 2002-11, pp. : 17-24

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Association d’anticorps anti-EGFR et anti-HER2

By Larbouret Christel   Robert Bruno   Teulon Isabelle   Azria David   Pèlegrin André  

Médecine/sciences, Vol. 23, Iss. 10, 2010-12 ,pp. : 800-803

Edp Sciences

Access to resources Recommend Favorite

Toward an individualizing therapy for colorectal cancer: the example of the anti-EGFR monoclonal antibodies

By Lièèvre Astrid   Laurent-Puig Pierre  

Personalized Medicine, Vol. 6, Iss. 2, 2009-03 ,pp. : 145-157

Future Medicine

Access to resources Recommend Favorite

Radioimmunotherapy of B-cell lymphoma with radiolabelled anti-CD20 monoclonal antibodies

By Dillman R.  

Clinical and Experimental Medicine, Vol. 6, Iss. 1, 2006-03 ,pp. : 1-12

Springer Publishing Company

Access to resources Recommend Favorite

Active Specific Immunotherapy of Malignant Melanoma with Anti‐idiotypic Monoclonal Antibodies

By  

THE JOURNAL OF DERMATOLOGY, Vol. 20, Iss. 9, 1993-09 ,pp. : 533-539

John Wiley & Sons Inc

Access to resources Recommend Favorite

Anti-HER2 Therapy in Elderly Breast Cancer Patients

By  

Reviews on Recent Clinical Trials, Vol. 9, Iss. 4, 2014-01 ,pp. : 263-266

Bentham Science Publishers

Access to resources Recommend Favorite